Bajaj Healthcare, 539872, BAJAJHCARE Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,803.25
N/A
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,985.48
0.18%
4.04

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.15
2.92
-11.37

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.23
9.60
-8.44

PAT CAGR (%)

10 Years
5 Years
3 Years

P:E (Median)

8 Years
5 Years
3 Years

16.88
15.32
15.66

P:BV (Average)

8 Years
5 Years
3 Years

3.38
3.38
3.01

EV:EBITDA (Average)

8 Years
5 Years
3 Years

10.39
10.92
12.41

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 133.09 101.21 31.50% 132.25 129.74 1.93% 133.90 154.11 -13.11% 108.57 132.57 -18.10%
Expenses 108.57 82.26 31.98% 107.74 107.99 -0.23% 117.87 132.09 -10.77% 89.04 102.14 -12.83%
EBITDA 24.52 18.95 29.39% 24.50 21.74 12.70% 16.03 22.02 -27.20% 19.54 30.43 -35.79%
EBIDTM 18.43% 18.72% 18.53% 16.76% 11.97% 14.29% 17.99% 22.96%
Other Income 2.61 1.22 113.93% 0.85 0.22 286.36% 6.45 0.72 795.83% 0.80 0.07 1,042.86%
Interest 7.88 8.26 -4.60% 8.44 8.75 -3.54% 6.01 5.97 0.67% 6.65 5.37 23.84%
Depreciation 6.81 6.66 2.25% 6.73 6.31 6.66% 7.30 4.69 55.65% 7.35 4.43 65.91%
PBT 12.45 5.24 137.60% 10.18 6.90 47.54% -35.15 12.08 - 6.33 20.71 -69.44%
Tax 4.10 0.12 3,316.67% 2.16 -0.12 - -3.15 0.93 - 0.80 3.96 -79.80%
PAT 8.34 5.12 62.89% 8.03 7.03 14.22% -32.00 11.15 - 5.52 16.75 -67.04%
PATM 6.27% 5.06% 6.07% 5.42% -23.90% 7.24% 5.09% 12.63%
EPS 2.64 1.62 62.96% 2.54 2.22 14.41% -10.13 3.53 - 1.75 5.30 -66.98%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 507.81 473.42 645.80 679.89 656.98 410.01 325.02 289.51 207.24 200.23 197.25 Net Sales Growth -1.90% -26.69% -5.01% 3.49% 60.24% 26.15% 12.27% 39.70% 3.50% 1.51% Cost Of Goods Sold 266.55 254.77 382.78 406.14 377.89 263.23 196.87 177.68 111.23 105.65 110.94 Gross Profit 241.26 218.65 263.01 273.75 279.09 146.78 128.15 111.83 96.01 94.57 86.31 GP Margin 47.51% 46.19% 40.73% 40.26% 42.48% 35.80% 39.43% 38.63% 46.33% 47.23% 43.76% Total Expenditure 423.22 397.08 534.32 561.23 520.62 361.73 282.09 250.08 176.40 170.18 168.43 Power & Fuel Cost - 31.47 37.69 31.83 24.96 24.24 21.83 19.81 16.79 14.12 13.42 % Of Sales - 6.65% 5.84% 4.68% 3.80% 5.91% 6.72% 6.84% 8.10% 7.05% 6.80% Employee Cost - 43.85 42.32 41.11 34.55 28.18 24.62 21.65 19.57 16.93 14.45 % Of Sales - 9.26% 6.55% 6.05% 5.26% 6.87% 7.57% 7.48% 9.44% 8.46% 7.33% Manufacturing Exp. - 38.89 34.11 59.68 64.02 28.56 25.07 21.53 19.89 23.16 22.73 % Of Sales - 8.21% 5.28% 8.78% 9.74% 6.97% 7.71% 7.44% 9.60% 11.57% 11.52% General & Admin Exp. - 10.54 11.08 12.74 11.03 7.95 6.64 5.06 5.76 5.87 5.03 % Of Sales - 2.23% 1.72% 1.87% 1.68% 1.94% 2.04% 1.75% 2.78% 2.93% 2.55% Selling & Distn. Exp. - 14.57 19.09 3.91 4.17 1.28 1.77 1.64 1.26 1.17 1.24 % Of Sales - 3.08% 2.96% 0.58% 0.63% 0.31% 0.54% 0.57% 0.61% 0.58% 0.63% Miscellaneous Exp. - 2.99 7.25 5.81 4.00 8.28 5.29 2.70 1.90 3.28 1.24 % Of Sales - 0.63% 1.12% 0.85% 0.61% 2.02% 1.63% 0.93% 0.92% 1.64% 0.31% EBITDA 84.59 76.34 111.48 118.66 136.36 48.28 42.93 39.43 30.84 30.05 28.82 EBITDA Margin 16.66% 16.13% 17.26% 17.45% 20.76% 11.78% 13.21% 13.62% 14.88% 15.01% 14.61% Other Income 10.71 8.69 1.59 1.44 6.91 6.53 0.97 2.07 2.39 0.38 0.07 Interest 28.98 29.75 17.68 12.78 8.34 6.63 8.32 7.73 8.20 7.64 8.02 Depreciation 28.19 27.62 17.21 17.64 16.12 12.12 11.41 11.08 11.35 9.29 8.86 PBT -6.19 27.65 78.18 89.68 118.82 36.06 24.17 22.68 13.69 13.50 12.02 Tax 3.91 -2.35 14.65 18.30 35.71 10.82 7.86 7.50 5.87 5.30 4.50 Tax Rate -63.17% 14.09% 18.74% 20.41% 30.05% 30.01% 32.52% 33.07% 42.88% 39.26% 37.44% PAT -10.11 -14.33 63.53 71.39 83.11 25.24 16.31 15.19 7.82 8.20 7.51 PAT before Minority Interest -10.11 -14.33 63.53 71.39 83.11 25.24 16.31 15.19 7.82 8.20 7.51 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -1.99% -3.03% 9.84% 10.50% 12.65% 6.16% 5.02% 5.25% 3.77% 4.10% 3.81% PAT Growth -125.24% - -11.01% -14.10% 229.28% 54.75% 7.37% 94.25% -4.63% 9.19% EPS -3.20 -4.53 20.10 22.59 26.30 7.99 5.16 4.81 2.47 2.59 2.38

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 278.36 367.69 328.49 258.41 177.93 129.11 113.61 99.00 88.63 81.93 Share Capital 13.80 13.80 13.80 13.80 13.80 6.90 6.90 6.90 6.75 3.75 Total Reserves 264.56 353.89 314.69 244.61 164.13 122.21 106.71 92.10 81.88 78.18 Non-Current Liabilities 23.43 96.37 70.54 84.65 27.40 20.41 23.45 27.69 32.26 22.24 Secured Loans 38.58 93.66 66.31 79.71 22.97 16.19 19.80 24.41 27.45 17.55 Unsecured Loans 0.00 0.00 0.00 0.00 0.60 1.20 1.68 2.43 4.00 4.67 Long Term Provisions 6.14 1.45 2.67 2.78 2.08 1.42 0.77 0.00 0.00 0.00 Current Liabilities 402.11 435.23 322.07 182.57 137.61 117.34 131.07 92.55 88.13 84.54 Trade Payables 89.43 84.75 104.92 68.95 57.48 29.98 43.38 18.85 16.17 22.75 Other Current Liabilities 51.07 47.55 31.44 24.98 21.18 25.62 25.93 20.02 20.06 18.91 Short Term Borrowings 261.48 289.42 176.20 88.47 58.43 54.89 54.52 39.16 42.29 37.42 Short Term Provisions 0.12 13.51 9.51 0.18 0.52 6.84 7.25 14.52 9.60 5.45 Total Liabilities 703.90 899.29 721.10 525.63 342.94 266.86 268.13 219.24 209.02 188.71 Net Block 252.75 365.69 269.74 208.13 162.24 128.50 126.62 127.93 129.56 108.50 Gross Block 422.98 525.01 401.73 329.25 267.83 222.23 209.65 199.88 191.39 161.81 Accumulated Depreciation 170.23 159.32 131.99 121.13 105.59 93.74 83.03 71.95 61.83 53.31 Non Current Assets 263.22 397.26 322.79 267.30 174.53 129.68 128.59 128.16 131.02 109.68 Capital Work in Progress 6.62 21.73 51.98 57.05 5.45 1.18 1.97 0.23 1.46 1.17 Non Current Investment 0.00 0.00 0.00 0.00 5.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 2.70 9.84 1.07 2.12 1.84 0.00 0.00 0.00 0.00 0.00 Current Assets 404.54 502.04 398.31 258.33 168.42 137.17 139.55 91.08 78.00 79.03 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 144.04 208.79 159.26 97.11 39.28 30.05 33.66 16.76 19.64 18.08 Sundry Debtors 180.24 194.17 184.51 98.88 98.48 78.13 80.38 52.69 42.95 51.52 Cash & Bank 2.93 19.23 1.98 14.24 4.16 7.86 8.29 0.84 0.36 0.87 Other Current Assets 77.33 35.58 37.59 32.00 26.50 21.13 17.21 20.79 15.04 8.56 Short Term Loans & Adv. 30.10 44.27 14.97 16.10 13.13 18.79 14.98 18.19 12.84 6.73 Net Current Assets 2.43 66.80 76.24 75.76 30.80 19.83 8.47 -1.47 -10.13 -5.51 Total Assets 667.76 899.30 721.10 525.63 342.95 266.85 268.14 219.24 209.02 188.71

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 92.29 -22.19 0.69 43.56 20.57 25.17 16.61 22.12 25.14 27.89 PBT -103.87 58.22 89.68 118.82 36.06 24.17 22.68 13.69 13.50 12.02 Adjustment 170.44 55.89 31.47 24.48 15.54 20.06 18.77 19.32 16.83 16.70 Changes in Working Capital 38.51 -124.76 -110.84 -64.09 -21.91 -6.04 -18.88 -5.81 -0.31 -0.08 Cash after chg. in Working capital 105.08 -10.66 10.32 79.21 29.70 38.19 22.58 27.20 30.03 28.63 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -12.79 -11.54 -9.63 -35.65 -9.12 -13.02 -5.96 -5.08 -4.89 -0.74 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -11.24 -93.43 -74.80 -108.93 -27.56 -13.03 -11.64 -8.45 -30.67 -16.71 Net Fixed Assets 117.14 -93.03 -67.41 -113.02 -49.87 -11.79 -11.51 -7.26 -29.87 -59.73 Net Investments 0.00 0.00 0.00 5.00 -5.00 0.00 0.00 0.00 0.00 0.00 Others -128.38 -0.40 -7.39 -0.91 27.31 -1.24 -0.13 -1.19 -0.80 43.02 Cash from Financing Activity -96.60 131.37 61.85 75.46 3.28 -12.57 2.47 -13.20 5.08 -11.36 Net Cash Inflow / Outflow -15.55 15.75 -12.27 10.08 -3.70 -0.42 7.45 0.47 -0.44 -0.18 Opening Cash & Equivalents 17.72 1.98 14.24 4.16 7.86 8.29 0.84 0.36 0.87 0.99 Closing Cash & Equivalent 2.17 17.72 1.98 14.24 4.16 7.86 8.29 0.84 0.42 0.81

Financial Ratios

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 100.86 133.23 119.02 93.63 64.47 64.41 52.73 71.74 34.33 27.64 ROA -1.74% 7.84% 11.45% 19.14% 8.28% 6.10% 6.23% 3.65% 4.12% 4.50% ROE -4.44% 18.25% 24.33% 38.09% 18.92% 20.18% 17.68% 10.77% 19.60% 22.38% ROCE 1.88% 14.02% 20.00% 35.91% 19.47% 19.75% 18.25% 14.52% 18.00% 19.16% Fixed Asset Turnover 2.00 2.79 1.86 2.20 1.67 1.71 1.60 1.18 1.26 1.66 Receivable days 72.17 53.51 76.07 54.82 78.61 78.15 74.24 75.67 77.37 88.85 Inventory Days 68.01 52.00 68.82 37.89 30.86 31.41 28.13 28.80 30.89 34.51 Payable days 124.77 90.43 78.13 61.06 43.87 46.86 44.67 35.97 41.39 56.94 Cash Conversion Cycle 15.40 15.08 66.76 31.65 65.59 62.70 57.71 68.50 66.87 66.43 Total Debt/Equity 1.19 1.13 0.78 0.70 0.51 0.91 1.19 0.76 1.75 1.77 Interest Cover 0.44 5.42 8.02 15.25 6.44 3.91 3.93 2.67 2.77 2.50

Top Investors:

vls finance ltd

hdfc mutual fund - hdfc pharma and healthcare fund

llp

Annual Reports:

News Update:

Bajaj Healthcare gets TGA’s approval for API Manufacturing Site in Gujarat
7th Dec 2024, 12:05 PM

The API Manufacturing Site has already received approval from USFDA and EU
Read More
Bajaj Healthcare enters into development and supply agreement with European Entity
23rd Sep 2024, 14:11 PM

Based on the outcome of these trials, the supplies will be done from the company’s FDA approved manufacturing facility situated at Savli, Vadodara
Read More

Bajaj Healthcare Ltd.

Pharmaceuticals & Drugs - API

BSE: 539872 | NSE: BAJAJHCARE

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update:

Bajaj Healthcare Ltd.

Pharmaceuticals & Drugs - API

BSE: 539872 | NSE: BAJAJHCARE

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update: